333 related articles for article (PubMed ID: 30596206)
21. Caffeine plus haloperidol reduces fatigue in an experimental model of Parkinson's disease - a prospective to A
de Bem Alves AC; Aguiar AS
Purinergic Signal; 2024 Feb; 20(1):29-34. PubMed ID: 36918462
[TBL] [Abstract][Full Text] [Related]
22. Functional roles of ST8SIA3-mediated sialylation of striatal dopamine D
Lin CY; Lai HL; Chen HM; Siew JJ; Hsiao CT; Chang HC; Liao KS; Tsai SC; Wu CY; Kitajima K; Sato C; Khoo KH; Chern Y
Transl Psychiatry; 2019 Aug; 9(1):209. PubMed ID: 31455764
[TBL] [Abstract][Full Text] [Related]
23. Balance between dopamine and adenosine signals regulates the PKA/Rap1 pathway in striatal medium spiny neurons.
Zhang X; Nagai T; Ahammad RU; Kuroda K; Nakamuta S; Nakano T; Yukinawa N; Funahashi Y; Yamahashi Y; Amano M; Yoshimoto J; Yamada K; Kaibuchi K
Neurochem Int; 2019 Jan; 122():8-18. PubMed ID: 30336179
[TBL] [Abstract][Full Text] [Related]
24. Rescue of locomotor impairment in dopamine D2 receptor-deficient mice by an adenosine A2A receptor antagonist.
Aoyama S; Kase H; Borrelli E
J Neurosci; 2000 Aug; 20(15):5848-52. PubMed ID: 10908627
[TBL] [Abstract][Full Text] [Related]
25. Exercise-Induced Adaptations to the Mouse Striatal Adenosine System.
Bauer EE; Buhr TJ; Reed CH; Clark PJ
Neural Plast; 2020; 2020():5859098. PubMed ID: 32399024
[TBL] [Abstract][Full Text] [Related]
26. Antipsychotic-Like Efficacy of Dopamine D
Sahlholm K; Gómez-Soler M; Valle-León M; López-Cano M; Taura JJ; Ciruela F; Fernández-Dueñas V
Mol Neurobiol; 2018 Jun; 55(6):4952-4958. PubMed ID: 28779351
[TBL] [Abstract][Full Text] [Related]
27. The antidepressant-like effect of guanosine involves the modulation of adenosine A
Camargo A; Bettio LEB; Rosa PB; Rosa JM; Altê GA; Rodrigues ALS
Purinergic Signal; 2023 Jun; 19(2):387-399. PubMed ID: 36166131
[TBL] [Abstract][Full Text] [Related]
28. Adenosine A
Massari CM; Constantino LC; Tasca CI
Purinergic Signal; 2021 Jun; 17(2):247-254. PubMed ID: 33548045
[TBL] [Abstract][Full Text] [Related]
29. Functional selectivity of allosteric interactions within G protein-coupled receptor oligomers: the dopamine D1-D3 receptor heterotetramer.
Guitart X; Navarro G; Moreno E; Yano H; Cai NS; Sánchez-Soto M; Kumar-Barodia S; Naidu YT; Mallol J; Cortés A; Lluís C; Canela EI; Casadó V; McCormick PJ; Ferré S
Mol Pharmacol; 2014 Oct; 86(4):417-29. PubMed ID: 25097189
[TBL] [Abstract][Full Text] [Related]
30. Intracellular calcium levels determine differential modulation of allosteric interactions within G protein-coupled receptor heteromers.
Navarro G; Aguinaga D; Moreno E; Hradsky J; Reddy PP; Cortés A; Mallol J; Casadó V; Mikhaylova M; Kreutz MR; Lluís C; Canela EI; McCormick PJ; Ferré S
Chem Biol; 2014 Nov; 21(11):1546-56. PubMed ID: 25457181
[TBL] [Abstract][Full Text] [Related]
31. Unique effect of clozapine on adenosine A
Valle-León M; Casajuana-Martin N; Del Torrent CL; Argerich J; Gómez-Acero L; Sahlholm K; Ferré S; Pardo L; Ciruela F
Biomed Pharmacother; 2023 Apr; 160():114327. PubMed ID: 36736280
[TBL] [Abstract][Full Text] [Related]
32. Heterobivalent Ligand for the Adenosine A
Pulido D; Casadó-Anguera V; Gómez-Autet M; Llopart N; Moreno E; Casajuana-Martin N; Ferré S; Pardo L; Casadó V; Royo M
J Med Chem; 2022 Jan; 65(1):616-632. PubMed ID: 34982555
[TBL] [Abstract][Full Text] [Related]
33. Modulation of adenosine signaling reverses 3-nitropropionic acid-induced bradykinesia and memory impairment in adult zebrafish.
Wiprich MT; Altenhofen S; Gusso D; Vasques RDR; Zanandrea R; Kist LW; Bogo MR; Bonan CD
Prog Neuropsychopharmacol Biol Psychiatry; 2022 Dec; 119():110602. PubMed ID: 35843370
[TBL] [Abstract][Full Text] [Related]
34. Caffeine and adenosine A
Alves CB; Almeida AS; Marques DM; Faé AHL; Machado ACL; Oliveira DL; Portela LVC; Porciúncula LO
Neuropharmacology; 2020 Apr; 166():107782. PubMed ID: 31756336
[TBL] [Abstract][Full Text] [Related]
35. Involvement of cAMP-PKA pathway in adenosine A1 and A2A receptor-mediated regulation of acetaldehyde-induced activation of HSCs.
Yang Y; Wang H; Lv X; Wang Q; Zhao H; Yang F; Yang Y; Li J
Biochimie; 2015 Aug; 115():59-70. PubMed ID: 25956975
[TBL] [Abstract][Full Text] [Related]
36. Altered adenosine 2A and dopamine D2 receptor availability in the 6-hydroxydopamine-treated rats with and without levodopa-induced dyskinesia.
Zhou X; Doorduin J; Elsinga PH; Dierckx RAJO; de Vries EFJ; Casteels C
Neuroimage; 2017 Aug; 157():209-218. PubMed ID: 28583881
[TBL] [Abstract][Full Text] [Related]
37. The adenosine A
Franco R; Navarro G; Martínez-Pinilla E
Int Rev Neurobiol; 2023; 170():49-71. PubMed ID: 37741696
[TBL] [Abstract][Full Text] [Related]
38. Adenosine signaling in striatal circuits and alcohol use disorders.
Nam HW; Bruner RC; Choi DS
Mol Cells; 2013 Sep; 36(3):195-202. PubMed ID: 23912595
[TBL] [Abstract][Full Text] [Related]
39. Loss-of-function of GNAL dystonia gene impairs striatal dopamine receptors-mediated adenylyl cyclase/ cyclic AMP signaling pathway.
El Atiallah I; Ponterio G; Meringolo M; Martella G; Sciamanna G; Tassone A; Montanari M; Mancini M; Castagno AN; Yu-Taeger L; Nguyen HHP; Bonsi P; Pisani A
Neurobiol Dis; 2024 Feb; 191():106403. PubMed ID: 38182074
[TBL] [Abstract][Full Text] [Related]
40. Striatopallidal adenosine A
Chen JF; Choi DS; Cunha RA
Neuropharmacology; 2023 Mar; 226():109421. PubMed ID: 36634866
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]